AI assistant
CONMED Corp — Director's Dealing 2018
Aug 6, 2018
31971_dirs_2018-08-06_5d65ef51-4db5-4cea-8166-b7ff53fcdef1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-08-02
Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-02 | Common Stock | M | 2000 | $32.93 | Acquired | 20347 | Direct |
| 2018-08-02 | Common Stock | F | 1221 | $80.40 | Disposed | 19126 | Direct |
| 2018-08-02 | Common Stock | M | 1560 | $44.90 | Acquired | 20686 | Direct |
| 2018-08-02 | Common Stock | F | 1106 | $80.40 | Disposed | 19580 | Direct |
| 2018-08-02 | Common Stock | M | 12000 | $51.30 | Acquired | 31580 | Direct |
| 2018-08-02 | Common Stock | F | 9133 | $80.40 | Disposed | 22447 | Direct |
| 2018-08-02 | Common Stock | S | 4000 | $79.73 | Disposed | 18447 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-02 | Sars (Stock Appreciation Rights) | $32.93 | M | 2000 | Disposed | 2023-06-01 | Common Stock (2000) | Direct |
| 2018-08-02 | Sars (Stock Appreciation Rights) | $44.90 | M | 1560 | Disposed | 2024-06-01 | Common Stock (1560) | Direct |
| 2018-08-02 | Sars (Stock Appreciation Rights) | $51.30 | M | 12000 | Disposed | 2025-02-27 | Common Stock (12000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.54 to $80.13. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.